Hans Ericsson

10PUBLICATIONS
23CO-AUTHORS
Medical virologyBasic pharmacologyGene and molecular therapyPharmacogenomicsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 10, 2026
Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial.

|Sep 03, 2026
Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics and the Pharmacokinetics of Balcinrenone When Dosed with a P-gp Inhibitor.

|Jul 03, 2026
The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

|May 08, 2026
Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor Mitiperstat.

|Feb 18, 2025
The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

Chandrali S Bhattacharya, Hans Ericsson, Susanne Johansson

|Oct 14, 2024
Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participants.

Xue-Qing Li, Bo Lindmark, Carl Amilon

Pageof 2

Frequent Collaborators

4 joint publications

Joanna Parkinson

3 joint publications

Mikael Sunnåker

2 joint publications

Karin Nelander

2 joint publications

Jane Knöchel